High-dose pyridoxine and magnesium administration in children with autistic disorder: An absence of salutary effects in a double-blind, placebo- controlled study

Journal of Autism and Developmental Disorders

Volumn 27, Issue 4, 1997, Pages 467-478

  Findling, Robert L ^a,b,c   Maxwell, Kathleen ^b   Scotese Wojtila, Lynette ^b   Huang, Jie ^a   Yamashita, Toyoko ^a   Wiznitzer, Max ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c Department of Psychiatry ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM; PLACEBO; PYRIDOXINE;

ADOLESCENT; AGGRESSION; AUTISM; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RATING SCALE; REVIEW;

ADOLESCENT; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MAGNESIUM OXIDE; MALE; PERSONALITY ASSESSMENT; PSYCHIATRIC STATUS RATING SCALES; PYRIDOXINE; TREATMENT FAILURE;

EID: 0030838974     PISSN: 01623257     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025861522935     Document Type: Review

References (44)

1. Aman, M. G., Van Bourgondien, M. E., Wolford, P. L., & Sarphare, G. (1995). Psychotropic and anticonvulsant drugs in subjects with autism: Prevalence and patterns of use. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1672-1681.
2. American Academy of Pediatrics, Committee on Nutrition. (1976). Megavitamin therapy for childhood psychoses and learning disabilities. Pediatrics, 58, 910-912.
3. American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed., rev.). Washington DC: Author.
4. Anderson, L. T., Campbell, M., Grega, D. M., Perry, R., Small, A. M., & Green, W. H. (1984). Haloperidol in the treatment of infantile autism: Effects on learning and behavioral symptoms. American Journal of Psychiatry, 141, 1195-1202.
5. Campbell, M., & Palij, M. (1985). Behavioral and cognitive measures used in psychopharmacologic studies of infantile autism. Psychopharmacology Bulletin, 21, 1047-1053.
6. Campbell, M., Anderson, L. T., Small, A. M., Adams, P., Gonzalez, N. M., & Ernst, M. (1993). Naltrexone in autistic children: Behavioral symptoms and attentional learning. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 1283-1291.
7. Coleman, M., Steinberg, G., Tippett, J., Bhagavan, H. N., Coursin, D. B., Gross, M., Lewis, C., & DeVeau, L. (1979). A preliminary study of the effect of pyridoxine administration in a subgroup of hyperkinetic children: A double-blind crossover comparison with methylphenidate Biological Psychiatry, 14, 741-751.
8. DeVeaugh-Geiss, J., Moroz, G., Biederman, J., Cantwell, D., Fontaine, R., Greist, J. H., Reichler, R., Katz, R., & Landau, P. (1992). Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder - a multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 45-49.
9. DiLalla, D. L., & Rogers, S. J. (1994). Domains of the Childhood Autism Rating Scale: Relevance for diagnosis and treatment. Journal of Autism and Developmental Disorders, 24, 115-128.
10. Dolske, M. C., Spollen, J., McKay, S., Lancashire, E., & Tolbert, L. (1993). A preliminary trial of ascorbic acid as supplemental therapy for autism. Progress in Neuropsychopharmacology and Biological Psychiatry, 17, 765-774.
11. Eisenberg, D. M., Kessler, R. C., Foster, C., Norlock, F. E., Calkins, D. R., & Delbanco, T. L. (1993). Unconventional medicine in the United States. New England Journal of Medicine, 328, 246-252.
12. Ernst, M., Devi, L., Silva, R. R., Gonzalez, N. M., Small, A. M., Malone, R. P., & Campbell, M. (1993). Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children. Psychopharmacology Bulletin, 29, 221-227.
13. Frankhauser, M. P., Karumanchi, V. C., German, M. L., Yates, A., & Karumanchi, S. D. (1992). A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism. Journal of Clinical Psychiatry, 53, 77-82.
14. Gillberg, C., Wahlstrom, J., Johansson, R., Tornblom, M., Albertson-Wikland, K. (1986). Folic acid as an adjunct in the treatment of children with the autism fragile-X syndrome (AFRAX). Developmental Medicine & Child Neurology, 28, 624-627.
15. Gonzalez, N. M., Campbell, M., Small, A. M., Shay, J., Bluhm, L. D., Adams, P. B., & Foltz, R. L. (1994). Naltrexone plasma levels, clinical response and effect on weight in autistic children. Psychopharmacology Bulletin, 30, 203-208.
16. Gordon, C. T., Rapoport, J. L., Hamburger, S. D., State, R. C., & Mannheim, G. B. (1992). Differential response of seven subjects with autistic disorder to clomipramine and desipramine. American Journal of Psychiatry, 149, 363-366.
17. Gordon, C. T., State, R. C., Nelson, J. E., Hamburger, S. D., & Rapoport, J. L. (1993). A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Archives of General Psychiatry, 50, 441-447.
18. Goyette, C. H., Conners, C. K., & Ulrich, R. F. (1978). Normative data on revised Conners parent and teacher rating scales. Journal of Abnormal Child Psychology, 6, 221-236.
19. Manning, R. M., & Zlotkin, S. H. (1985). Unconventional eating practices and their health implications. Pediatric Clinics of North America, 32, 429-445.
20. Insel, T. R., Murphy, D. L., Cohen, R. M., Alterman, I., Kilts, C., & Linnoila, M. (1983). Obsessive-compulsive disorder: A double-blind trial of clomipramine and clorgyline. Archives of General Psychiatry, 40, 605-612.
21. Jakobs, C., Jaeken, J., & Gibson, K. M. (1993). Inherited disorders of GABA metabolish. Journal of Inherited Metabolic Disease, 16, 704-715.
22. Jaselskis, C. A., Cook, E. H., Jr., Fletcher, K. E., & Leventhal, B. L. (1992). Clonidine treatment of hyperactive and impulsive children with autistic disorder. Journal of Clinical Psychopharmacology, 12, 322-327.
23. Kolmen, B. K., Feldman, H. M., Handen, B. L., & Janosky, J. E. (1995). Naltrexone in young autistic children; A double-blind, placebo-controlled crossover study. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 223-231.
24. Lelord, G., Muh, J. P., Barthelemy, C., Martineau, J., Garreau, B., & Callaway, E. (1981). Effects of pyridoxine and magnesium on autistic symptoms-initial observations. Journal of Autism and Developmental Disorders, 11, 219-230.
25. Leventhal, B. L., Cook, E. H., Jr., Morford, M., Ravitz, A. J., Heller, W., & Freedman, D. X. (1993). Clinical and neurochemical effects of fenfluramine in children with autism. Journal of Neuropsychiatiy and Clinical Neurosciences, 5, 307-315.
26. 6-Mg: Therapeutic effects in childhood autism. Biological Psychiatry, 20, 467-478.
27. 6-magnesium administration in an autistic child. Biological Psychiatry, 21, 511-518.
28. 6-magnesium in a subgroup of autistic children selected on their sensitivity to this treatment. Journal of Autism and Developmental Disorders, 18, 435-447.
29. McLachlan, R. S., & Brown, W. F. (1995). Pyridoxine dependent epilepsy with iatrogenic sensory neuronopathy. Canadian Journal of Neurologic Sciences, 22, 50-51.
30. Menage, P., Thibault, G., Barthélèmy, C., Lelord, G., & Bardos, P. (1992). CD4+CD45RA+T lymphocyte deficiency in autistic children: Effect of a pyridoxine-magnesium treatment. Brain Dysfunction, 5, 326-333.
31. National Institute of Mental Health. (1985). Clinical Global Impression Scale. Psychopharmacology Bulletin, 21, 839-843.
32. Overall, J. E., & Campbell, M. (1988). Behavioral assessment of psychopathology in children: Infantile autism. Journal of Clinical Psychology, 44, 708-716.
33. Pauling, L. (1974). On the orthomolecular environment of the mind: Orthomolecular theory. American Journal of Psychiatry, 131, 1251-1257.
34. Pfeiffer, S. I., Norton, J., Nelson, L., & Shott, S. (1995). Efficacy of vitamin B6 and magnesium in the treatment of autism: A methodology review and summary of outcomes. Journal of Autism and Developmental Disorders, 25, 481-493.
35. Quintana, H., Birmaher, B., Stedge, D., Lennon, S., Freed, J., Bridge, J., & Greenhill, L. (1995). Use of methylphenidate in the treatment of children with autistic disorder. Journal of Autism and Developmental Disorders, 25, 283-294.
36. Rimiand, B. (1988). Controversies in the treatment of autistic children: Vitamin and drug therapy. Journal of Child Neurology, 3(Suppl), S68-S72.
37. 6 on autistic children: A double-blind crossover study. American Journal of Psychiatry, 135, 472-475.
38. Schaumberg, H., Kaplan, J., Windebank, A., Vick, N., Rasmus, S., Pleasure, D., & Brown, M. J. (1983). Sensory neuropathy from pyridoxine abuse: A new megavitamin syndrome. New England Journal of Medicine, 309, 445-448.
39. Schopler, E., Reichler, R., DeVellis, R., & Daly, K. (1980). Toward objective classification of childhood autism: Childhood autism rating scale (CARS). Journal of Autism and Developmental Disorders, 10, 91-103.
40. Schulz, K. F., Chalmers, I., Hayes, R. J., & Altman, D. G. (1995). Empiric evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association, 273, 408-412.
41. Spigelblatt, L., Laine-Ammara, G., Pless, B., & Guyver, A. (1994). The use of alternative medicine by children. Pediatrics, 94, 811-814.
42. Tolbert, L., Haigler, T., Waits, M. M., & Dennis, T. (1993). Brief report: Lack of response in an autistic population to a low dose clinical trial of pyridoxine and magnesium. Journal of Autism and Developmental Disorders, 23, 193-199.
43. Willemsen-Swinkels, S. H. N., Buitelaar, J. K., Nijhof, G. J., & van Engeland, H. (1995). Failure of naltrexone hydrochloride to reduce self-injuries and autistic behavior in mentally retarded adults: Double-blind placebo-controlled studies. Archives of General Psychiatry, 52, 766-773.
44. Wolraich, M. L., Wilson, D. B., & White, J. W. (1995). The effect of sugar on behavior or cognition in children: A meta-analysis. Journal of the American Medical Association, 274, 1617-1621.